TIBER CREEK for CIGNA CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, and the Health Care and Education Reconciliation Act. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017. H.R.5963, To delay the reimposition of the annual fee on health insurance providers until after 2020, regarding relief from the Health Insurance Tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JAY HEIMBACH | — |
| ANDREW MCKECHNIE | — |
| JEFF SHAPIRO | — |
Health Issues HCR
Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, , including exchanges, cost sharing reduction, market reforms, and non-discrimination provisions. The high cost employer health insurance excise tax, including H.R. 173 and S. 58, the Middle Class Health Benefits Tax Repeal Act of 2017, and H.R. 4616, the Employer Relief Act of 2018, regarding a one-year delay of the Cadillac Tax. H.R. 4620, the Protecting Families and Small Businesses Act of 2017, regarding relief from the Health Insurance Tax. Substance use disorders and 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records, specifically H.R. 3545, H.R. 5795, and H.R.6082, the Overdose Prevention and Patient Safety Act (OPPS Act) and H.R. 6, the SUPPORT for Patients and Communities Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JAY HEIMBACH | — |
| ANDREW MCKECHNIE | — |
| JEFF SHAPIRO | — |
Medicare/Medicaid MMM
Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to the opioid epidemic and H.R. 6, SUPPORT for Patients and Communities Act. Issues related to the drug pricing RFI, the Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Issues related to implementation of provisions in the Bipartisan Budget Act of 2018 that require increased integration of Medicare and Medicaid benefits by Dual Eligible Special Needs Plans beginning in 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JAY HEIMBACH | — |
| ANDREW MCKECHNIE | — |
| JEFF SHAPIRO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.